Cargando…

Long Non-Coding RNA Expression Profile Associated with Malignant Progression of Oral Submucous Fibrosis

Oral submucous fibrosis (OSF) as one of the premalignant disorders endures a series of histopathological stages to invasive oral squamous cell carcinoma (OSCC) eventually. However, the role of long non-coding RNA (lncRNA) expression in OSF malignant progression still remains poorly understood. Throu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Shanghui, Zhu, Yun, He, Zhijing, Zhang, Dahe, Guo, Feng, Jian, Xinchun, Zhang, Chenping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699286/ https://www.ncbi.nlm.nih.gov/pubmed/31467541 http://dx.doi.org/10.1155/2019/6835176

Ejemplares similares

Exosome‐derived long non‐coding RNA ADAMTS9‐AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway
por: Zhou, Shanghui, et al.
Publicado: (2020)

Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis
por: Zhou, Shanghui, et al.
Publicado: (2015)

Long Non-Coding RNAs in Oral Submucous Fibrosis: Their Functional Mechanisms and Recent Research Progress
por: He, Yaodong, et al.
Publicado: (2021)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma
por: Li, Zhenming, et al.
Publicado: (2023)

Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
por: Karnam, Shyamala, et al.
Publicado: (2022)

Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis
por: Chen, Jun, et al.
Publicado: (2022)

Oral submucous fibrosis and plasma lipid profile
por: Pantvaidya, G. H., et al.
Publicado: (2013)

Evaluation of Hematological Profile in Oral Submucous Fibrosis
por: Abidullah, Mohammed, et al.
Publicado: (2022)

Correction to: Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis
por: Chen, Jun, et al.
Publicado: (2022)

Research Achievements of Oral Submucous Fibrosis: Progress and Prospect
por: Xu, Hui, et al.
Publicado: (2021)

Identification of a combined biomarker for malignant transformation in oral submucous fibrosis
por: Bazarsad, Shadavlonjid, et al.
Publicado: (2016)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis
por: Chaudhary, Minal, et al.
Publicado: (2015)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis
por: Jyothi Meka, Naga, et al.
Publicado: (2015)

The role of myofibroblasts in the progression of oral submucous fibrosis: A systematic review
por: Wadhwan, Vijay, et al.
Publicado: (2019)

Malignant potentiality assessment of oral submucous fibrosis through semi-quantitative approach
por: Pal, Mousumi, et al.
Publicado: (2020)

Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets
por: Qin, Xiaofeng, et al.
Publicado: (2023)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation
por: Sharma, Mohit, et al.
Publicado: (2020)

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
por: Monteiro, Roshni, et al.
Publicado: (2021)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis
por: Murthy, Vignesh, et al.
Publicado: (2022)

Serum lipid profile in oral submucous fibrosis: A clinico pathological study
por: Kanthem, Ranjith Kumar, et al.
Publicado: (2015)

Evaluation of Hematological profile in Oral Submucous Fibrosis: A Cross-sectional Study
por: Patil, Deepa Jatti, et al.
Publicado: (2020)

Bioinformatics analysis of miRNA and its associated genes to identify potential biomarkers of oral submucous fibrosis and oral malignancy
por: Mohanan, Ezhuthachan Mithu, et al.
Publicado: (2023)

Mechanistic Investigation of Curcuma Protection against Oral Submucous Fibrosis
por: Peng, Haiyan, et al.
Publicado: (2022)

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mohapatra, Diksha, et al.
Publicado: (2023)

Buccal fat pad reconstruction for oral submucous fibrosis
por: Surej, Kumar L. K., et al.
Publicado: (2010)

Ultrasonographic Evaluation of Oral Submucous Fibrosis and Masseteric Hypertrophy
por: Devathambi, Jones Raja, et al.
Publicado: (2013)

Prognostic potential of AgNORs in oral submucous fibrosis
por: Murgod, Sanjay, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rbraefa92icnp8qkjjntgi14pm